|
|
|
Services
Resources:
Trilogy Intro...
SITE SEARCH P.O. Box 471 Tel 508.359.7806 |
Staff
Trilogy Associates is a small firm consisting of a core team of associates with access to a larger cadre of collaborating consultants and affiliated firms with whom we have worked and whose competence we respect. Joseph Kalinowski, the founding Principal of the firm, takes a role -- often a lead role -- in every client-sponsored engagement. Our core team's guiding principle is that a combination of sound technology grounding and preparation along with successful, multifunction business experience is essential to deliver actionable client benefits. Brief biosketches of core team members follow. Joseph J. KalinowskiJoe Kalinowski, Principal of Trilogy Associates, founded the management consulting firm in 1989 following a 24-year career in industry building businesses with new products.Kalinowski began his career as an engineer following his attainment of bachelor's and master's degrees in electrical engineering from Rutgers University and the University of Illinois. His career started with the Aerospace Physics Laboratory of GE's Missile and Space Division. He then joined Battelle Memorial Institute as an expert in computer-aided design, where he spent five years executing and marketing contract research programs for numerous government and industrial clients. Joe then joined the Corning corporate R&D organization. Over a period of 11 years, he was affiliated with Corning's medical and laboratory businesses in positions of increasing responsibilities for research, development, program management, line management, and eventually venture management for an emerging business in medical informatics for Ciba Corning Diagnostics (now Bayer Diagnostics). Mr. Kalinowski then joined Ohmeda as Director of R&D for its noninvasive monitoring business in pulse oximetry. He was later recruited to join the management team of Betagen, a young biotechnology venture in DNA blot imaging, analysis, and preparation. He served as Vice President of Development with responsibility for existing products and the formulation of new business opportunities in the creation of tools for biotechnology research. He took on an interim responsibility as Director of Business Development for Deknatel, a surgical devices firm, immediately following its leveraged buyout from Pfizer. At Deknatel (now part of Genzyme Biosurgery) he identified numerous new product opportunities for growth, brought initiatives through the business planning stage, and developed external alliances for new business. Mr. Kalinowski has led Trilogy Associates since its formation, developing the practice and serving clients ranging in size from start-ups to Fortune-100 multinationals in industries including clinical diagnostics, laboratory and process instruments, surgical devices, pharmaceuticals, implanted devices, patient monitoring, biotechnology, electronics, specialty chemicals, medical informatics, utilities and publishing. He brings to each consulting engagement his technological awareness, business acumen, and an ability to identify and fully appreciate real client needs. He has been elected to membership in Sigma Xi, Tau Beta Pi and Eta Kappa Nu honoraries and has published in 11 professional journals. Alan M. Ganz, Ph.D.Alan Ganz has a technology consulting practice specializing in the development of analytical instruments. He is developing fiberoptic-coupled instrumentation for real time measurements of dynamic processes in manufacturing. Additionally, he is involved in designing a novel apparatus for noninvasive medical diagnostics with a team from Johns Hopkins University and a private research lab. Dr. Ganz is frequently called on to do patent analysis and support. In his role as a management consultant, Ganz works with companies not only in evaluating concepts and projects but also in implementing fresh ideas to enhance those business opportunities. His ongoing responsibility in the lab ensures that his management advice remains realistic, up-to-date and sensitive to the evolving capacity of R&D staff. Dr. Ganz received his B.A. in physics (Summa Cum Laude, Phi Beta Kappa) from CCNY and his Ph.D. in physics from Columbia University. He began his industrial career at Exxon Production Research, where his spectroscopic studies of surfactant solutions were tied to novel ways of extracting oil. From the bench, Ganz then moved to a think tank, Mission Research, which specialized in defense studies conducted by computer modeling. As group leader in the infrared program, he was responsible for projects with major aerospace companies as well as with the U.S. government. This position led to his assuming the Program Manager role for an Air Force Space Optics project in PerkinElmer’s government business. In 1987 Dr. Ganz moved to the commercial side of PerkinElmer’s business in the Applied Technology Group. He was later promoted to lead an experimental unit charged with creating devices for noninvasive medical diagnostics. Reporting to the Chief Technology Officer, he performed both management functions and scientific investigations. Since leaving PerkinElmer in 1998, Dr. Ganz has had clients ranging from individual entrepreneurs, funding projects based at prestigious universities, to Fortune-100 companies. Having done work with institutions including Johns Hopkins Medical Center, UC Berkeley, Sarnoff Labs and Los Alamos National Laboratories, he is well connected to many of the scientific leaders in medical, materials and bioscience technologies. Randall H. MorseRandy Morse consults on technology, product, market and business issues for emerging life science companies. He has been responsible for the development and commercialization of over 30 life science products, including reagents, other consumables, analytical instruments and software. His work at startup, jump-start, private and public international life science companies has afforded him extensive hands-on experience in building infrastructure and providing leadership and guidance to a variety of enterprises. Morse began his industrial career after receiving a master's degree in biology from Cornell University. He served in executive sales, marketing, R&D and business development roles over a 20-year period with Schleicher & Schuell, now an international market leader in molecular biology tools. He then served as Vice President of Marketing at Genetic Biosystems, a VC-backed startup in DNA sequencing systems. After taking on an interim business development role with an emerging electro-optics firm, Mr. Morse joined Packard BioChip Technologies (now PerkinElmer) as Director of Marketing for microarray instruments and software, where he introduced numerous laser scanners, printers and imaging software packages for microarray analysis. Randy founded his consulting practice in 2002, concentrating on engagements dealing with due diligence, partnering, market research and strategic planning. Russell N. ChuteRuss Chute began his career as an engineer after receiving a bachelor’s degree in industrial engineering from Cornell University, joining Procter & Gamble as a systems consultant for manufacturing and subsequently holding a series of manufacturing positions -- production supervisor, quality control and production planning manager, and plant manager -- over a seven-year period. Chute received an MBA from MIT and joined FMC Corporation as a strategic planning consultant in its Chemical Group. He subsequently became Division Manufacturing Manager of a pharmaceutical specialty chemical division, then Strategic Planning Manager and New Venture Manager in a newly acquired division that ultimately achieved significant profit growth with a strategic focus on specialty chemicals for the biotechnology industry. Mr. Chute co-founded Endeco Medical as President and COO, where he commercialized a new medical electronic device after raising funds from private investors. He then joined CP Ventures/Evergreen Company, where he provided organization and strategy development consulting to portfolio companies and made venture capital investments in early stage medical, biotechnology and telecommunications firms. Several of his investments are now successful public companies. Chute later co-founded Millenium Medical, where he pioneered a new system for reusable laparoscopic surgical instruments. Since 1990, Mr. Chute has provided strategic business planning and product/market evaluation services for companies in the medical device and laboratory instrumentation industries. William T. DowneyBill Downey began his professional career at American Cyanamid as a chemical engineer in pollution control, identifying reactions with potential for pollution discharge, performing field surveys, and establishing laboratory procedures. Following his receipt of a master's degree in engineering from Dartmouth College, he headed a division of Enertech, commercializing residential and commercial solar heating systems. Following his receipt of an MBA from the Georgia Institute of Technology, he entered consulting practice at Arthur D. Little, Inc., initially in the Engineering Sciences section. There he consulted to industrial and government clients on the markets, technologies and economics of conventional and renewable energy sources. He subsequently joined the Management Counseling section of ADL and participated in strategic planning, due diligence, market research and financial analysis cases dealing with medical electronics, electronic components, hydraulic actuators, waste heat recuperators, industrial heat pumps and CAD/CAM systems. He spent several months in Pakistan studying the industrialization effects of rural electrification. Mr. Downey later joined Technology Consulting Group, ultimately becoming Vice President of that management consulting firm, with responsibilities for business development and project management. He directed numerous strategic planning, business acquisition, market research, plant siting, competitive analysis and new-product development projects for industrial clients in medical, pharmaceutical, personal care, consumer, architectural, raw materials, chemicals, plastics, die casting, industrial machinery, financial services, process control and transportation industries. Bill's recent work with Trilogy Associates has included management consulting engagements dealing with medical diagnostics, automated microbiology, bioprocessing and electric utilities. He brings extensive awareness and experiences in industrial materials, components and systems to Trilogy. Downey is a member of several technical societies, the Dartmouth Engineering Society and the academic honor society Beta Gamma Sigma. Downey has published books and articles on renewable and conventional energy resources, labor law, industrial marketing models, the impact of Federal policy on energy usage, and the die casting industry. Philip G. Drew, Ph.D.Phil Drew provides data and analyses to users and manufacturers of medical imaging equipment. For hospitals and radiologists he provides strategic planning services, program and space planning studies, studies of financial and organizational feasibility, and related assistance. For manufacturers and others interested in the commercial aspects of medical imaging he provides technological and market forecasts based on analysis of technical, clinical, operational and competition-related factors, as well as assistance in strategic planning, product planning and acquisition studies. He is a principal author of seven major multi-client studies, one on the outlook for the medical imaging equipment industry in the U.S. and Japan, four on the outlook for electronic medical imaging (otherwise called picture archiving and communication systems), and two on the outlook for magnetic resonance imaging. These studies are designed to give clients necessary data and analysis for strategic planning. In addition, they allow Dr. Drew to perform specialized analyses, such as acquisition studies, product planning studies, feasibility studies, and equipment selection, starting from a systematic base of knowledge of the industry, its suppliers and their products. He led a team that worked with senior management of the Mallinckrodt Institute of Radiology, which provides all diagnostic imaging services as well as radiation oncology services for the Washington University Medical Center in St. Louis, to develop a strategic plan for the Institute in the 1990s; he also led the teams that undertook new strategic planning efforts there. He led a similar effort for the Department of Radiology for the State University of New York at Stony Brook. He also led an operational audit of all activities -- clinical, teaching, research, and administration -- of the Cardiovascular Division of the Washington University School of Medicine. Formerly, Dr. Drew was a senior member of the staff of Arthur D. Little, Inc. His work there involved a wide range of medical and hospital products as well as programming and design of hospital facilities and analysis of hospital operations. Dr. Drew received his B.S. in mechanical engineering from Carnegie-Mellon University; his M.S. in applied mathematics from Harvard University; and his Ph.D. in electrical engineering from Harvard. He has published over 100 articles on various aspects of medical imaging. He is a registered professional engineer in the Commonwealth of Massachusetts, a contributing editor of Diagnostic Imaging magazine, and former Chairman of the Society for Computer Applications in Radiology. Kimberly Fortier GruidlKim Gruidl is a market research and editorial consultant with special emphasis in the biomedical and chemicals sectors. Following early work as a research chemist, Ms. Fortier Gruidl began her market research career in 1990 when she joined Teltech Network Resources as a research analyst. During her tenure at Teltech, Gruidl helped launch its Indepth Custom Research business as part of a core team of senior managers. She has conducted market opportunity assessments, competitive benchmarking studies and technology evaluations for various medical products industry clients ranging from Fortune-100 multinationals to start-ups. She holds a BS in chemical/biomedical engineering from the University of Minnesota and an MA in English from Colorado State University. Ms. Gruidl began her association with Trilogy Associates in 1999. In that capacity she has conducted extensive market research with clinicians in healthcare-provider and research institutions and developed written materials to fulfill specific strategic and instructional objectives. She brings extraordinary capabilities in clinician interactions, strategic analysis and clear exposition. © 1998-2008 Trilogy Associates. All rights reserved. Return to Home Page. |
